PD-L1 Biomarker Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Cancer Type (NSCLC, Kidney Cancer, Melanoma, Head and Neck, Bladder Cancer, Others), By Assay Kit Type (PD-L1 22C3 IHC, PD-L1 28-8 IHC, PD-L1 SP263, PD-L1 SP142), By End Use (Research and Development, Diagnostics) By Region and Competition

Published	Pages	Publisher	Report code
Nov 2023	178	TechSci Research	ASDR-640774

Published: Nov 2023 - Pages : 178 - Publisher : TechSci Research - Report code : ASDR-640774

1. AstraZeneca PLC
2. Merck Group (SigmaAldrich Co. LLC)
3. F. Hoffmann-La Roche Ltd.
4. Abcam
5. Agilent technologies
6. NeoGenomics Laboratories Inc.
7. ACROBiosystems
8. PerkinElmer Inc.
9. Guardant Health
10. Quanterix

Global Liquid Biopsy Market - Forecast to 2031

This report can be of interest as well:

Global Liquid Biopsy Market - Forecast to 2031

Published: May, 2024 | Report code: ASDR-665927